Drugs Market Research Reports & Industry Analysis

The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.

Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.

A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.

Publications found: 9,295
Sort by:

Investigation Report on China's Doxorubicin Market 2021-2025

US$ 2,600.00

Doxorubicin belongs to the anthracycline class (Anthracycline) antibiotics, which can inhibit the synthesis of RNA and DNA. It has a strong inhibitory effect on RNA and has a broad anti-tumor spectrum...

June 2021 50 pages

Investigation Report on China's Emtricitabine/Tenofovir Market 2021-2025

US$ 2,600.00

Emtricitabine/Tenofovir is the first HIV drug approved for prophylaxis. It was developed by Gilead Sciences Inc (the original drug is called TRUVADA). Its product was first approved in the United Stat...

June 2021 50 pages

Investigation Report on China's Enteral Nutrition Market 2021-2025

US$ 2,600.00

Enteral nutrition is mainly used for preoperative feeding of patients with anorexia and related diseases, including mechanical gastrointestinal dysfunction, critical illness and malnutrition. It was d...

June 2021 50 pages

Investigation Report on China's Express Delivery Industry 2021-2025

US$ 2,600.00

Express delivery is a door-to-door logistics activity with postal functions, which means express companies use rail, road, and air transportation to quickly deliver customers' goods. According to CRI’...

June 2021 50 pages

Investigation Report on China's Goserelin Market 2021-2025

US$ 2,600.00

Goserelin is a synthetic analogue of a naturally occurring gonadotropin-releasing hormone (GnRH). Goserelin is developed by AstraZeneca, is mainly used to treat advanced breast and prostate cancer. In...

June 2021 50 pages

Investigation Report on China's Hydrotalcite Market, 2021-2025

US$ 2,600.00

Hydrotalcite is suitable for acute and chronic gastritis, reflux esophagitis, gastric and duodenal ulcers, stomach pain, heartburn, acid belching, fullness and other uncomfortable symptoms related to...

June 2021 50 pages

Investigation Report on China's Insulin Glargine Market 2021-2025

US$ 2,600.00

Insulin Glargine is a long-acting human insulin analog that can control the patient's blood sugar more effectively and steadily. It is often used to treat type 1 and type 2 diabetes. Its original rese...

June 2021 50 pages

Investigation Report on China's Leuprorelin Market 2021-2025

US$ 2,600.00

Leuprolide is a synthetic gonadotropin drug used to treat hormone-responsive cancers such as prostate cancer and breast cancer. It can also be used to treat precocious puberty and prevent premature ov...

June 2021 50 pages

Investigation Report on China's Levofloxacin Market 2021-2025

US$ 2,600.00

Levofloxacin, developed by Daiichi Sankyo, is used to treat bacterial infectious diseases such as community pneumonia, sinusitis, urinary tract infections. Levofloxacin tablets were approved in China...

June 2021 50 pages

Investigation Report on China's Moxifloxacin Market 2021-2025

US$ 2,600.00

Moxifloxacin is a fourth-generation synthetic quinolone antibacterial drug (8-methoxy-fluoroquinolone antibiotic) developed by Bayer Vital GmbH. It was approved for marketing by the FDA in December 19...

June 2021 50 pages

Investigation Report on Global and China's MOSFET Market 2021-2025

US$ 2,600.00

MOSFET is an acronym for Metal Oxide Semiconductor Field Effect Transistor, also known as MOS, MOS transistor. The name 'metal–oxide–semiconductor' (MOS) typically refers to a type of insulated-gate f...

June 2021 50 pages

Global Erythropoietin Drugs Market Size study, By Drug Class (Biologics, Biosimilars), By Product (Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, Others), By Application (Cancer, Hematology, Neurology and Renal Diseases) and Regional Forecasts 2021-2027

US$ 3,750.00

Global Erythropoietin Drugs Market is valued approximately USD 11.05 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 11.30% over the forecast period 2021-2027. Eryth...

June 2021 200 pages

Global Vitamin D Therapy Market Size study, by Route of administration (Oral and Parenteral), Age Group (Children, Adult, Senior Adult), Purchase Pattern (OTC, Prescription), Application (Osteoporosis, Rickets, Autoimmune Disorder, Skin Diseases and Others) and Regional Forecasts 2021-2027

US$ 3,750.00

Global Vitamin D Therapy Market is valued approximately USD 2.11 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 11.3% over the forecast period 2021-2027. Vitamin D...

June 2021 200 pages

Investigation Report on China's Daratumumab Market 2021-2025

US$ 2,600.00

Daratumumab, developed by Johnson & Johnson, is a monoclonal antibody available for the treatment of myeloma. Its product DARZALEX was approved for the treatment of patients with multiple myeloma who...

June 2021 50 pages

Investigation Report on China's Docetaxel Market 2021-2025

US$ 2,600.00

Docetaxel, sold under the brand name Taxotere, is a paclitaxel anti-tumor drug used for the treatment of locally advanced or metastatic non-small cell lung cancer. Docetaxel injection was first develo...

June 2021 50 pages

Investigation Report on China's Liraglutide Market 2021-2025

US$ 2,600.00

Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, developed by Novo Nordisk A/S. Its product VICTOZA firstly launched in the EU in July 2009 and firstly approved to enter the Chinese...

June 2021 50 pages

Investigation Report on China's Omalizumab Market 2021-2025

US$ 2,600.00

Omalizumab, developed by Novartis Europharm, is the only approved antibody designed to target and block immunoglobulin E (IgE). At the end of 2017, the FDA approved the registration of Novartis Europh...

June 2021 50 pages

Investigation Report on China's Oxaliplatin Market 2021-2025

US$ 2,600.00

Oxaliplatin (OXA) is the third-generation platinum anti-tumor drug after cisplatin and carboplatin. Oxaliplatin was jointly developed by Sanofi and Debiopharm for the first-line treatment of metastati...

June 2021 50 pages

Investigation Report on China's Pantoprazole Market 2021-2025

US$ 2,600.00

Pantoprazole is the third proton pump inhibitor marketed globally. Compared with omeprazole, it has higher selectivity and bioavailability. Pantoprazole is more stable than omeprazole and lansola unde...

June 2021 50 pages

Investigation Report on China's Pertuzumab Market 2021-2025

US$ 2,600.00

Pertuzumab is the first monoclonal antibody called 'HER dimerization inhibitor'. It mainly used to treat HER2-positive breast cancer. It was developed by Genentech, a subsidiary of Roche Pharma (Schwe...

June 2021 50 pages

Investigation Report on China's Rabeprazole Market 2021-2025

US$ 2,600.00

Rabeprazole is a kind of proton pump inhibitor (PPI) gastric acid inhibitor. It is used for the treatment of gastroesophageal reflux disease and maintenance treatment after recovery. It is also suitab...

June 2021 50 pages

Investigation Report on China's Ruxolitinib Market 2021-2025

US$ 2,600.00

Ruxolitinib was developed by Novartis Pharma Schweiz AG. It is an orally bioavailable Janus-associated kinase (JAK) inhibitor with selectivity for subtypes JAK1 and JAK2. Its product is used for the t...

June 2021 50 pages

Investigation Report on China's Sitagliptin Market 2021-2025

US$ 2,600.00

Sitagliptin is the world's first listed oral dipeptidyl peptidase-4 (DPP-4) inhibitor, developed by Merck Sharp & Dohme Ltd (JANUVIA). It was approved by the U.S. FDA in October 2006 to be used as a s...

June 2021 50 pages

Drug Discovery Informatics - Global Market Outlook (2020-2028)

US$ 4,150.00

... Drug Discovery Informatics market. However, Lack of information technology and critical attributes of data evaluation are limiting the market growth. The recent trends in Drug Discovery Informatics are considerable shift observed from traditional in-vitro drug development to computer aided drug designing, as costly failures of late drug development increases ...

June 2021 150 pages

Global Injectable Drugs Market (2021 Edition) – Analysis By Molecule (Small, Large), Delivery (Prefilled, Infusion, Others), Product, By Region, By Country: Market Insights and Forecast with Impact of Covid-19 (2021-2026)

US$ 2,200.00

EXECUTIVE SUMMARY The Global Injectable Drugs Market was valued at USD 414.88 Billion in the year 2020. Increasing prevalence of diseases such as diabetes, cancer and auto-immune disorders like rheum...

May 2021 230 pages

Global Psychedelic Drugs Market (2021 Edition) – Analysis By Drug, Route of Administration, Distribution Channel, By Region, By Country: Market Insights, Pipeline Drugs and Forecast with Impact of Covid-19 (2021-2026)

US$ 2,200.00

EXECUTIVE SUMMARY The Covid-19 pandemic has restricted the movement of people, confining them in their homes, caused severe trauma and stress in the form of sadness and loneliness and has affected th...

May 2021 260 pages

Investigation Report on China's Abiraterone Market 2021-2025

US$ 2,600.00

Abiraterone is a CYP17 inhibitor, which is mainly clinically used to treat prostate cancer patients. Its product ZYTIGA was developed by Janssen-Cilag International NV(a subsidiary of Johnson & Johnso...

May 2021 50 pages

Investigation Report on China's Butylphthalide Market 2021-2025

US$ 2,600.00

Butylphthalide, developed by CSPC Enbipu Pharmaceutical Co. Ltd is used to treat mild to moderate acute ischemic stroke. Its soft capsule was approved in China in 2005, and its injection was approved...

May 2021 50 pages

Investigation Report on China's Dasatinib Market 2021-2025

US$ 2,600.00

Dasatinib, developed by Bristol-Myers Squibb, is an anti-tumor drug. It was first approved by the FDA in 2006 for the treatment of adult patients with Philadelphia chromosome-positive (Ph+) chronic my...

May 2021 50 pages

Investigation Report on China's Dolutegravir Market 2021-2025

US$ 2,600.00

Dolutegravir was developed by GlaxoSmithKline for the treatment of HIV-infected adults and children over 12 years old. Its product TIVICAY was approved in China in 2016 and was approved for children's...

May 2021 50 pages

Investigation Report on China's Esomeprazole Market 2021-2025

US$ 2,600.00

Esomeprazole is a proton pump inhibitor (PPI), which can effectively inhibit gastric acid secretion. It is clinically used to treat gastric acid-related diseases such as gastroesophageal reflux diseas...

May 2021 50 pages

Investigation Report on China's Golimumab Market 2021-2025

US$ 2,600.00

Golimumab is an immunosuppressive medication that can effectively regulate inflammation and bone metabolism. The trade name of Golimumab is SIMPONI, which was developed by Janssen Biologics BV. Its pr...

May 2021 50 pages

Investigation Report on China's Paclitaxel Market 2021-2025

US$ 2,600.00

Paclitaxel is a chemotherapeutic tumor drug used to treat metastatic breast cancer after failure of combination chemotherapy or relapse within 6 months after adjuvant chemotherapy. Its product, develo...

May 2021 50 pages

Investigation Report on China's Pegylated Recombinant Human Granulocyte Colony Stimulating Factor (PEG-rhG-CSF) 2021-2025

US$ 2,600.00

Pegylated Recombinant Human Granulocyte Colony Stimulating Factor (PEG-rhG-CSF) is an effective drug for the prevention and treatment of neutropenia or deficiency caused by tumor radiotherapy or chemo...

May 2021 50 pages

Investigation Report on China's Piperacillin and Tazobactam Market 2021-2025

US$ 2,600.00

Piperacillin and Tazobactam is a compound anti-infective drug composed of piperacillin (semi-synthetic penicillin antibiotic) and tazobactam (?-lactamase inhibitor). It is suitable for moderate and se...

May 2021 50 pages

Investigation Report on China's Propofol Market 2021-2025

US$ 2,600.00

Propofol is a short-acting intravenous anesthetic. Its uses include the induction and maintenance of general anesthesia, sedation for mechanically ventilated adults, and procedural sedation. It is als...

May 2021 50 pages

Investigation Report on China's Tiotropium Bromide Market 2021-2025

US$ 2,600.00

Tiotropium Bromide, developed by Boehringer Ingelheim International GmbH, is used to treat chronic obstructive pulmonary disease (COPD). Its product SPIRIVA was approved in China in 2006. In 2017, Tio...

May 2021 50 pages

Investigation Report on China's Tocilizumab Market 2021-2025

US$ 2,600.00

The trade name of Tocilizumab is ACTEMRA, which was developed by Roche Pharma (Schweiz) AG. In 2013, its product was firstly approved in China and its indication is RA. Tocilizumab was approved in Chi...

May 2021 50 pages

Investigation Report on China's Voriconazole Market 2021-2025

US$ 2,600.00

Voriconazole is used to treat progressive, potentially life-threatening fungal infections. Its product was developed by Pfizer. It was approved in China in 2004. By 2020, there are 11 manufacturers of...

May 2021 50 pages

Investigation Report on Chinese Compound Amino Acid Market 2021-2025

US$ 2,600.00

Compound Amino Acid is clinically used for patients with insufficient protein intake, malabsorption, and other amino acids that cannot meet the requirements of body metabolism. It was developed by Jap...

May 2021 50 pages

Global Antipsychotic Drugs Market Size study, Antipsychotic Drugs Market by Drug Class (First Generation, Second Generation, Third Generation and Others), by Application (Schizophrenia, Dementia, Bipolar and Unipolar Depression) and Regional Forecasts 2021-2027

US$ 3,750.00

Global Antipsychotic Drugs Market is valued approximately USD 12.67 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 1.95% over the forecast period 2021-2027. A “psyc...

May 2021 200 pages

Drug Testing Market Size, Share & Trends Analysis Report By Product Type (Consumables, Instruments, Rapid Testing Devices, Services), By Sample Type, By Drug Type, By End Use, By Region, And Segment Forecasts, 2021 - 2028

US$ 5,950.00

This report can be delivered to the clients within 72 Business Hours Drug Testing Market Growth & Trends The global drug testing market size is expected to reach USD 11.7 billion by 2028, according...

May 2021 120 pages

Investigation Report on China's Dulaglutide Market 2021-2025

US$ 2,600.00

Description Dulaglutide is a weekly long-acting GLP-1 receptor agonist developed by Eli Lilly and was approved to enter China in 2019. Dulaglutide is suitable for the blood glucose control of adult pa...

May 2021 50 pages

Investigation Report on China's Funeral Market 2021-2025

US$ 2,600.00

DESCRIPTION The funeral and interment industry can be divided into four parts from the perspective of service content: funeral services, disposal of remains, cemetery services, and other funeral produ...

May 2021 50 pages

Investigation Report on China's Palbociclib Market 2021-2025

US$ 2,600.00

Description Palbociclib is the world's first selective inhibitor of CDK 4/6 launched by Pfizer. By inhibiting CDK 4/6, Palbociclib restores cell cycle control, thereby blocking tumor cell proliferatio...

May 2021 50 pages

Investigation Report on China's Ustekinumab Market 2021-2025

US$ 2,600.00

Ustekinumab is a monoclonal antibody medication developed by Janssen Pharmaceuticals. It is mainly used to treat psoriasis, Crohn's disease, and ulcerative colitis. Janssen’s Ustekinumab, STELARA was...

May 2021 50 pages

Investigation Report on Chinese Salmeterol/Ticasone Market 2021-2025

US$ 2,600.00

Description Salmeterol/Ticasone is a compound medication used in regular treatment of asthma and chronic obstructive pulmonary disease (COPD). Its original drug was developed by GlaxoSmithKline. In 20...

May 2021 50 pages

Breast Cancer Treatment Drug Markets in China

US$ 4,000.00

China's demand for Breast Cancer Treatment Drug has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high...

May 2021 256 pages

1,3 Beta Glucan Synthase (EC 2.4.1.34) - Drugs in Development, 2021

US$ 3,000.00

1,3 Beta Glucan Synthase (EC 2.4.1.34) - Drugs in Development, 2021 SUMMARY 1,3 Beta Glucan Synthase (EC 2.4.1.34) - Drugs in Development, 2021 provides in depth analysis on 1,3 Beta Glucan Synthase (...

April 2021 30 pages

Filters

Search

Publishers

1
318
174
29
4
667
409
35
27
971
77
19
16
425
2
21
1
16
111
1
5
9
2,264
5
4
31
6
142
1
17
15
248
651
89
1
373
26
34
586
1
2
16
6
4
84
36
3
4
2
7
15
53
16
26
83
11
32
8
2
17
109
28
19
4
7
3
324
15
1
23
72
24
29
44
296
17
18
2

Regions

131
40
38
37
37
35
32
21
12
10
10
9
9
8
8
8
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
5
5
5
5
4
4
3
3
3
3
3
90
12
354
31
6
6
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
2
2
2
38
4
4
3
3
3
1
1
3
9
7,953

Price

Date

Pages

Offers

9
1